Comparison of Physical Activity and Fiber and Sugar Intake in Patients with Nonalcoholic Fatty Liver Disease with Healthy Individuals

Document Type : Research Paper


1 Department of Clinical Nutrition and Dietetics, Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran

2 National Nutrition and Food Technology Research Institute, Faculty of Nutrition Sciences and Food Technology, Shahid Behehshti University of Medical Sciences, Tehran , Iran

3 Student Research Committee, Department Nutrition, Urmia University of Medical Sciences, Urmia, Iran

4 Department of Biostatistics and Epidemiology, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran


Introduction: Nutrition as a modifiable risk factor that plays an important role in prevent or delay the onset of non-alcoholic fatty liver disease (NAFLD). Thus, the aim of the current study was to assess and compare physical activity, dietary fiber and sugar intake between non-alcoholic fatty liver disease and healthy individuals.Methods: The present case-control study was done on 225 cases of NFLD and 450 controls. International Physical Activity Questionnaire and Food Frequency questionnaire were used respectively to assess the physical activity level and dietary intake of individuals. Anthropometric measurements included weight, height, body mass index (BMI) and waist to hip ratio ware calculated for the subjects. All data were analysed using SPSS version 21.0. Results: the result of our study showed that the physical activity level of NAFLD patients were lower than control group (P<0.05). For the insoluble dietary fiber, we observed a significant lower consumption in the case group as compared to the control group (P<0.05). The fructose, galactose, total sugar, and glucose variables showed significant increase in the case group (P<0.05). Conclusions: Our results indicated that following unhealthy diet such as high consumption of simple carbohydrates such as glucose, fructose, and galactose might be related to NAFLD. However, consuming dietary fiber and insoluble fiber may play protective roles in NAFLD.


1. Harte AL, da Silva NF, Creely SJ, McGee KC, Billyard T, Youssef-Elabd EM, et al. Elevated endotoxin levels in non-alcoholic fatty liver disease. J Inflamm (Lond). 2010; 7(1):15.
2. Nahandi MZ, Khoshbaten M, Ramazanzadeh E, Abbaszadeh L, Javadrashid R, Shirazi KM, et al. Effect of non-alcoholic fatty liver disease on carotid artery intima-media thickness as a risk factor for atherosclerosis. Gastroenterol Hepatol Bed Bench. 2014; 7(1): 55-62.
3. Sharma M, Mitnala S, Vishnubhotla RK, Mukherjee R, Reddy DN, Rao PN. The riddle of nonalcoholic fatty liver disease: progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis. J Clin Exp Hepatol. 2015; 5(2): 147-58.
4. Alisi A, Nobili V. Overlapping clinical features between NAFLD and metabolic syndrome in children. Eur Med J Hepatol. 2014; 1: 55-61.
5. Adibi A, Maleki S, Adibi P, Etminani R, Hovsepian S. Prevalence of Nonalcoholic Fatty Liver Disease and its Related Metabolic Risk Factors in Isfahan, Iran. Adv Biomed Res. 2017; 6: 47.
6. Nseir W, Hellou E, Assy N. Role of diet and lifestyle changes in nonalcoholic fatty liver disease. World J Gastroenterol. 2014; 20(28): 9338-44.
7. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005; 112(17): 2735-52.
8. Chen ZW, Chen LY, Dai Hl, Chen JH, Fang LZ. Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease. J Zhejiang Univ Sci B. 2008; 9(8): 616-22.
9. Gaby AR. Adverse effects of dietary fructose. Altern Med Rev. 2005; 10(4): 294-306.
10. Glushakova O, Kosugi T, Roncal C, Mu W, Heinig M, Cirillo P, et al. Fructose induces the inflammatory molecule ICAM-1 in endothelial cells. J Am Soc Nephrol. 2008; 19(9): 1712-20.
11. Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, Webb M, Blendis L, Halpern Z, et al. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. J Hepatol. 2007; 47(5): 711-7.
12. Cortez-Pinto H, Jesus L, Barros H, Lopes C, Moura MC, Camilo M. How different is the dietary pattern in non-alcoholic steatohepatitis patients? Clin Nutr. 2006; 25(5): 816-23.
13. Popkin BM. The nutrition transition and its health implications in lower-income countries. Public Health Nutr. 1998; 1(1): 5-21.
14. Popkin BM, Duffey K, Gordon-Larsen P. Environmental influences on food choice, physical activity and energy balance. Physiol Behav. 2005; 86(5): 603-13.
15. Kistler KD, Brunt EM, Clark JM, Diehl AM, Sallis JF, Schwimmer JB. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. Am J Gastroenteroly. 2011; 106(3): 460-8.
16. Nishida C, Uauy R, Kumanyika S, Shetty P. The joint WHO/FAO expert consultation on diet, nutrition and the prevention of chronic diseases: process, product and policy implications. Public Health Nutr. 2004; 7(1A): 245-50.
17. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003; 35(8): 1381-95.
18. Esmaillzadeh A, Kimiagar M, Mehrabi Y, Azadbakht L, Hu FB, Willett WC. Dietary patterns, insulin resistance, and prevalence of the metabolic syndrome in women. Am J Clin Nutr. 2007; 85(3): 910-8.
19. Helmerhorst HJ, Wijndaele K, Brage S, Wareham NJ, Ekelund U. Objectively measured sedentary time may predict insulin resistance independent of moderate-and vigorous-intensity physical activity. Diabetes. 2009; 58(8): 1776-9.
20. St George A, Bauman A, Johnston A, Farrell G, Chey T, George J. Independent effects of physical activity in patients with nonalcoholic fatty liver disease. Hepatology. 2009; 50(1): 68-76.
21. Lai HS, Lin WH, Chen PR, Wu HC, Lee PH, Chen WJ. Effects of a high-fiber diet on hepatocyte apoptosis and liver regeneration after partial hepatectomy in rats with fatty liver. JPEN J Parenter Enteral Nutr. 2005; 29(6): 401-7.
22. Hashemi Kani A, Alavian SM, Esmaillzadeh A, Adibi P, Azadbakht L. Dietary quality indices and biochemical parameters among patients with non alcoholic fatty liver disease (NAFLD). Hepat Mon. 2013; 13(7): e10943.
23. Thomas AP, Dunn TN, Drayton JB, Oort PJ, Adams SH. A dairy‐based high calcium diet improves glucose homeostasis and reduces steatosis in the context of preexisting obesity. Obesity (Silver Spring). 2013; 21(3): E229-35.
24. Leach NV, Dronca E, Vesa SC, Sampelean DP, Craciun EC, Lupsor M, et al. Serum homocysteine levels, oxidative stress and cardiovascular risk in non-alcoholic steatohepatitis. Eur J Intern Med. 2014; 25(8): 762-7.
25. Basaranoglu M, Basaranoglu G, Bugianesi E. Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction. Hepatobiliary Surg Nutr. 2015; 4(2): 109-16.
26. Silbernagel G, Machann J, Unmuth S, Schick F, Stefan N, Häring HU, et al. Effects of 4-week very-high-fructose/glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids: an exploratory trial. Br J Nutr. 2011; 106(1): 79-86.
27. Toshimitsu K, Matsuura B, Ohkubo I, Niiya T, Furukawa S, Hiasa Y, et al. Dietary habits and nutrient intake in non-alcoholic steatohepatitis. Nutrition. 2007; 23(1): 46-52.
28. Nikroo H, Mohammadian M, Nematy M, Sima HR, Attarzadeh Hosseini SR. The effect of diet and exercise on improvement of quality of life in patients with nonalcoholic steatohepatitis. Journal of Kerman University of Medical Sciences. 2014; 21(1): 61-72.
29. Radu C, Grigorescu M, Crisan D, Lupsor M, Constantin D, Dina L. Prevalence and associated risk factors of non-alcoholic fatty liver disease in hospitalized patients. J Gastrointestin Liver Dis. 2008; 17(3): 255-60.
30. Khoshbaten M, Fatahi E, Soomi H, Tarzmani M, Farhang S, Majidi G, et al. Clinico-biochemical comparison of patients with Nonalcoholic fatty liver disease and healthy populace. Zahedan Journal of Research in Medical Sciences. 2009;11(1): e94431.
31. Pang Q, Zhang JY, Song SD, Qu K, Xu XS, Liu SS, et al. Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index. World J Gastroenterol. 2015; 21(5): 1650-62.